In a report published Wednesday, Citigroup reiterated its Buy rating on Eastman Chemical Company EMN, and raised its price target from $57.00 to $62.00.
Citigroup noted, “We rate the shares of EMN Buy. Management has significantly transformed its portfolio over the past several years by divesting parts of its CASPI product lines, PE & PET assets, followed by the acquisition of specialty plasticizer assets of Genovique and Sterling. Rounding out the portfolio transformation was the acquisition of Solutia, which is a true specialty company as seen from its EBITDA margins of 25%. The Solutia deal also gives EMN a good footprint in Asia-Pacific, where Solutia derived ~30% of sales in 2011. We think EMN has transformed its portfolio significantly, much ahead of many chemical competitors including restarting its propane-based cracker in Longview, TX in 2010 to take advantage of ‘shale supremacy' in the US.”
Eastman Chemical Company closed on Tuesday at $52.28.
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
date | ticker | name | Price Target | Upside/Downside | Recommendation | Firm |
---|
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in